Preliminary research by Mayo Clinic shows that high-dose plasma therapy is correlated with fewer deaths in patients with severe COVID-19. A 10 percentage point difference in deaths was found when ...
Plasma from people who have recovered from the coronavirus could be a tool in helping critically ill patients recover from the virus, and the region’s two largest health care providers are working ...
More COVID-19 patients are expected to receive convalescent plasma therapy since the Trump administration issued an emergency authorization Sunday, backed by research from the Mayo Clinic in Rochester ...
While the number of people dying from the novel coronavirus in the United States is on the decline, people are continuing to be infected with the virus throughout the country. Currently, experimental ...
MOBILE, Ala. (WKRG) — Infirmary Health says twelve patients, including several physicians, who successfully recovered from COVID-19 have agreed to donate their plasma to help heal other COVID-19 ...
DAYTON, Ohio (WDTN) – Two frontline workers were among the first to donate plasma since the Community Blood Center (CBC) launched the Dayton region’s COVID-19 Convalescent Plasma program (CCP). Before ...
DAYTON, Ohio (WDTN) – The Community Blood Center’s new COVID-19 Convalescent Plasma program will allow Miami Valley residents who have recovered from the virus to contribute to patient treatment. The ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. STILLWATER, Okla. (KFOR) – Officials say ...
Newark’s University Hospital and the American Red Cross on Monday said they completed the emergency COVID-19 convalescent plasma collection program at the Newark facility that began on May 11.
About a month ago, University of Iowa Health Care began enlisting recovered COVID-19 patients to donate plasma as part of a clinical trial to determine if antibodies in survivors can help patients ...
Walsh said an emergency use authorization from the FDA would make it easier for physicians to access the plasma and administer it, but the current system is enough to allow access as it is. Emergency ...
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked. By Katie Thomas and Noah ...